Alongside Fidelity Biosciences as co-lead of Liazon's round was venture capital (VC) firm Bessemer Venture Partners.

Liazon, a US-based operator of a private health benefits exchange, has raised $18.2m from a syndicate including mutual fund manager Fidelity’s corporate venturing unit.

Alongside Fidelity Biosciences as co-lead of Liazon’s round was venture capital (VC) firm Bessemer Venture Partners.

VC firms Bain Capital Ventures and Rand Capital reinvested in the round, which earlier in the month had included Ingleside Investors (also known as AC Israel Enterprises), an integrated investment firm that primarily represents the interests of the New…